Upfront treatment for newly diagnosed transplant-ineligible multiple myeloma patients: a systematic review and network meta-analysis of 14,533 patients over 29 …
L Sekine, PK Ziegelmann, D Manica… - Critical reviews in …, 2019 - Elsevier
Choice of treatment for newly diagnosed transplant-ineligible multiple myeloma poses a
difficult task due to an ever-increasing plethora of different regimens. Attempting to clarify …
difficult task due to an ever-increasing plethora of different regimens. Attempting to clarify …
Upfront treatment for newly diagnosed transplant-ineligible multiple myeloma patients: A systematic review and network meta-analysis of 14,533 patients over 29 …
L Sekine, PK Ziegelmann, D Manica… - Critical Reviews in …, 2019 - europepmc.org
Choice of treatment for newly diagnosed transplant-ineligible multiple myeloma poses a
difficult task due to an ever-increasing plethora of different regimens. Attempting to clarify …
difficult task due to an ever-increasing plethora of different regimens. Attempting to clarify …
Upfront treatment for newly diagnosed transplant-ineligible multiple myeloma patients: A systematic review and network meta-analysis of 14,533 patients over 29 …
L Sekine, PK Ziegelmann, D Manica… - Critical reviews in …, 2019 - pubmed.ncbi.nlm.nih.gov
Choice of treatment for newly diagnosed transplant-ineligible multiple myeloma poses a
difficult task due to an ever-increasing plethora of different regimens. Attempting to clarify …
difficult task due to an ever-increasing plethora of different regimens. Attempting to clarify …